Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Resmed Inc (NYSE: RMD) closed at $221.11 down -0.42% from its previous closing price of $222.05. In other words, the price has decreased by -$0.42 from its previous closing price. On the day, 0.67 million shares were traded. RMD stock price reached its highest trading level at $225.555 during the session, while it also had its lowest trading level at $220.66.
Ratios:
For a deeper understanding of Resmed Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 62.22 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.33. For the most recent quarter (mrq), Quick Ratio is recorded 2.29 and its Current Ratio is at 3.33. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on March 19, 2025, initiated with a Overweight rating and assigned the stock a target price of $280.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 10 ’25 when Sandercock Brett sold 1,000 shares for $230.36 per share. The transaction valued at 230,360 led to the insider holds 90,864 shares of the business.
Ghoshal Kaushik sold 9,745 shares of RMD for $2,332,096 on Mar 10 ’25. The Chief Commercial Officer, SaaS now owns 9,725 shares after completing the transaction at $239.31 per share. On Mar 07 ’25, another insider, Farrell Michael J., who serves as the Chief Executive Officer of the company, sold 8,009 shares for $229.20 each. As a result, the insider received 1,835,692 and left with 455,472 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RMD now has a Market Capitalization of 32473763840 and an Enterprise Value of 32791535616. As of this moment, Resmed’s Price-to-Earnings (P/E) ratio for their current fiscal year is 26.12, and their Forward P/E ratio for the next fiscal year is 21.11. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.87. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.59 while its Price-to-Book (P/B) ratio in mrq is 6.18. Its current Enterprise Value per Revenue stands at 6.656 whereas that against EBITDA is 19.151.
Stock Price History:
The Beta on a monthly basis for RMD is 0.76, which has changed by 0.15161455 over the last 52 weeks, in comparison to a change of 0.08190584 over the same period for the S&P500. Over the past 52 weeks, RMD has reached a high of $263.05, while it has fallen to a 52-week low of $172.19. The 50-Day Moving Average of the stock is -5.99%, while the 200-Day Moving Average is calculated to be -3.98%.
Shares Statistics:
For the past three months, RMD has traded an average of 969.57K shares per day and 988290 over the past ten days. A total of 146.86M shares are outstanding, with a floating share count of 145.81M. Insiders hold about 0.72% of the company’s shares, while institutions hold 63.32% stake in the company. Shares short for RMD as of 1740700800 were 8730591 with a Short Ratio of 9.00, compared to 1738281600 on 8300270. Therefore, it implies a Short% of Shares Outstanding of 8730591 and a Short% of Float of 6.84.
Dividends & Splits
According to the company, the forward annual dividend rate for RMD is 2.07, from 2.02 in the trailing year. Against a Trailing Annual Dividend Yield of 0.00909705The stock’s 5-year Average Dividend Yield is 0.83. The current Payout Ratio is 27.75% for RMD, which recently paid a dividend on 2025-02-13 with an ex-dividend date of 1739404800. Stock splits for the company last occurred on 2010-08-31 when the company split stock in a 2:1 ratio.
